Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren J Strittmatter

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|February 26, 2013
Bathing the brainWarren J Strittmatter
Current Opinion in Lipidology|March 14, 2002
Molecular biology of apolipoprotein EWarren J Strittmatter, Carol Bova Hill
Methods in Enzymology|October 19, 2006
Phage display screening for peptides that inhibit polyglutamine aggregationDaniel J Kenan, Warren J Strittmatter, James R Burke
Biochemical and Biophysical Research Communications|January 24, 2006
Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondriaKasturi L Puranam, Guanghong Wu, Warren J Strittmatter, et al.
Archives of Biochemistry and Biophysics|February 1, 2003
In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's diseaseAlexander V Panov, James R Burke, Warren J Strittmatter, et al.
Journal of Lipid Research|February 1, 2007
High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDLMirta Mihovilovic, Jennifer B Robinette, Robert M DeKroon, et al.
Neuroscience Letters|April 18, 2002
Expanded polyglutamine stretches form an 'aggresome'Takayoshi Shimohata, Aki Sato, James R Burke, et al.
Assay and Drug Development Technologies|October 18, 2007
Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assayLora Hamuro, Guangtao Zhang, Timothy J Tucker, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 19, 2013
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseasesH Akiko Popiel, Toshihide Takeuchi, James R Burke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2005
APOE2 allele increased in tardive dyskinesiaJonathan Halford, Gandis Mazeika, Susan Slifer, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|February 26, 2013
Bathing the brainWarren J Strittmatter
Current Opinion in Lipidology|March 14, 2002
Molecular biology of apolipoprotein EWarren J Strittmatter, Carol Bova Hill
Methods in Enzymology|October 19, 2006
Phage display screening for peptides that inhibit polyglutamine aggregationDaniel J Kenan, Warren J Strittmatter, James R Burke
Biochemical and Biophysical Research Communications|January 24, 2006
Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondriaKasturi L Puranam, Guanghong Wu, Warren J Strittmatter, et al.
Archives of Biochemistry and Biophysics|February 1, 2003
In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's diseaseAlexander V Panov, James R Burke, Warren J Strittmatter, et al.
Journal of Lipid Research|February 1, 2007
High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDLMirta Mihovilovic, Jennifer B Robinette, Robert M DeKroon, et al.
Neuroscience Letters|April 18, 2002
Expanded polyglutamine stretches form an 'aggresome'Takayoshi Shimohata, Aki Sato, James R Burke, et al.
Assay and Drug Development Technologies|October 18, 2007
Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assayLora Hamuro, Guangtao Zhang, Timothy J Tucker, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 19, 2013
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseasesH Akiko Popiel, Toshihide Takeuchi, James R Burke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2005
APOE2 allele increased in tardive dyskinesiaJonathan Halford, Gandis Mazeika, Susan Slifer, et al.
Pageof 3